Skip to content

In the BioHarmony Drug Report Database


Idefirix (imlifidase) is an enzyme pharmaceutical. Imlifidase was first approved as Idefirix on 2020-08-25. It has been approved in Europe to treat immunologic desensitization and kidney transplantation.
Trade Name Idefirix
Common Name Imlifidase
Indication immunologic desensitization, kidney transplantation
Drug Class Enzymes
Get full access now